Dr. Kahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1660 S Columbian Way
Seattle, WA 98108Phone+1 206-277-5515Fax+1 206-764-2693
Education & Training
- University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1988
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1983 - 1985
- University of Cape Town Faculty of MedicineClass of 1978
Certifications & Licensure
- WA State Medical License 1986 - 2025
- PA State Medical License 1984 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2009
- Elected Member The American Society for Clinical Investigation, 2000
Clinical Trials
- Insulin, Neurogenetics and Memory in Alzheimer's Disease Start of enrollment: 1999 Oct 01
- Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
- RISE Adult Medication Study Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 1094 citationsRelationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.Miriam Cnop, Peter J. Havel, Kristina M. Utzschneider, Daniel B. Carr, Madhur K. Sinha
Diabetologia. 2003-04-10 - 699 citationsEffect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinica...Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn
JAMA. 2019-01-01 - 354 citationsEffect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.Julio Rosenstock, Steven E. Kahn, Odd Erik Johansen, Bernard Zinman, Mark A. Espeland
JAMA. 2019-09-24
Journal Articles
- A Call for Improved Reporting of Human Islet Characteristics in Research ArticlesSteven E Kahn, Kevan C Herold, Maureen Gannon, Diabetologia
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal RiskSteven E Kahn, John H Alexander, Robert D Toto, Darren K McGuire, JAMA
- Genetic Ancestry Markers and Difference in A1c Between African-American and White in the Diabetes Prevention ProgramSteven Kahn, William C Knowler, Kieren J Mather, Jose C Florez, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
- New SELECT Trial Analysis with Semaglutide 2.4 Mg Showed a Significant Reduction in Hospital Admissions in Adults with Known Heart Disease and Obesity or OverweightNovember 3rd, 2024
- Tirzepatide Leads to Long-Term Glucose ControlSeptember 25th, 2024
- Blood Sugar Meds Against Type 2 DiabetesJuly 1st, 2021
- Join now to see all
Grant Support
- Pathogenesis And Impact Of Islet AmyloidVeterans Affairs2011–2012
- Diabetes Endocrinology Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
- Diabetes Prevention Program Outcomes Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Optimizing Recovery And Preservation Of Endogenous Insulin SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Mechanisms Of Islet AmyloidogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Study Of Health Outcomes Of Weight Loss: Look Ahead-Action For Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Post-Ddp Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2008
- Impact Of Short-Term Hyperglycemia On Cell Function And Insulin SensitivityNational Center For Research Resources2006–2007
- Study Of Health Outcomes Of Weight-Loss (SHOW)National Institute Of Diabetes And Digestive And Kidney Diseases2006
- Study Of Health Outcomes Of Weight-Loss (SHOW)National Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
- Islet Function In Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Clinical Center For Look Ahead: Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- NIDDM Primary Prevention Trial (Dpp-2)National Institute Of Diabetes And Digestive And Kidney Diseases1997–2002
- Dietary Fat On Insulin Sensitivity &Islet Beta Cell FunctionNational Center For Research Resources2000
- Role Of Dietary Fat On Insulin Sensitivity &Islet Beta Cell FunctionNational Center For Research Resources1999–2000
- European Association For Study Of Diabetes International Training CouNational Center For Research Resources1999–2000
- Mechanism Of Islet Amyloid FormationNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
- NIDDM Primary Prevention Trial (Dpp 2)National Institute Of Diabetes And Digestive And Kidney Diseases1998
- NIDDM Primary Prevention Trial (Dpt-2)National Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
- Genetics Of NIDDMNational Center For Research Resources1996
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: